Virology Market 2025 to 2034
Virology Market 2025 to 2034
Virology Market (By Product Type: Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons; By Application: Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract Infections, Eye Infections, CNS Infections, Sexually Transmitted Diseases, Perinatal Infections; By End User: Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, Pharmacies; By Region: North America, LAMEA, Europe, Asia-Pacific) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2035
Customisation Request
Revenue, 2025
USD 3
Forecast Year, 2035
USD 4.92 Bn
CAGR, 2025 - 2035
5.07%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global virology market, valued at over USD 3 billion in 2025, is projected to reach approximately USD 4.92 billion by 2035, growing at a CAGR of 5.07%, driven by rising infectious disease prevalence and advancements in diagnostics and therapeutics.
Virology Market Size Analysis
Virology Market Size By Product Type 2025 to 2034 (USD Billion)
| Product Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Diagnosing Test | 0.30 | 0.32 | 0.33 | 0.35 | 0.37 | 0.39 | 0.41 | 0.43 | 0.45 | 0.47 |
| Viral Infection Controlling Methods | 0.60 | 0.63 | 0.66 | 0.70 | 0.73 | 0.77 | 0.81 | 0.84 | 0.89 | 0.94 |
| Antiviral Chemotherapy | 0.90 | 0.94 | 0.99 | 1.04 | 1.10 | 1.15 | 1.21 | 1.27 | 1.34 | 1.40 |
| Interferons | 1.20 | 1.26 | 1.32 | 1.39 | 1.46 | 1.54 | 1.61 | 1.69 | 1.78 | 1.87 |
Virology Market Size By Application 2025 to 2034 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Skin and Soft Tissue Infections | 0.08 | 0.09 | 0.09 | 0.10 | 0.10 | 0.11 | 0.11 | 0.12 | 0.12 | 0.13 |
| Respiratory Tract Infections | 0.17 | 0.18 | 0.18 | 0.19 | 0.20 | 0.21 | 0.22 | 0.24 | 0.25 | 0.26 |
| GI Tract Infections | 0.25 | 0.26 | 0.28 | 0.29 | 0.30 | 0.32 | 0.34 | 0.35 | 0.37 | 0.39 |
| Urinary Tract Infections | 0.33 | 0.35 | 0.37 | 0.39 | 0.41 | 0.43 | 0.45 | 0.47 | 0.50 | 0.52 |
| Eye Infections | 0.42 | 0.44 | 0.46 | 0.48 | 0.51 | 0.53 | 0.56 | 0.59 | 0.62 | 0.65 |
| CNS Infections | 0.50 | 0.52 | 0.55 | 0.58 | 0.61 | 0.64 | 0.67 | 0.71 | 0.74 | 0.78 |
| Sexually Transmitted Diseases | 0.58 | 0.61 | 0.64 | 0.68 | 0.71 | 0.75 | 0.78 | 0.82 | 0.87 | 0.91 |
| Perinatal Infections | 0.67 | 0.70 | 0.73 | 0.77 | 0.81 | 0.85 | 0.90 | 0.94 | 0.99 | 1.04 |
Virology Market Size By End User 2025 to 2034 (USD Billion)
| End User | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 0.14 | 0.15 | 0.16 | 0.17 | 0.18 | 0.19 | 0.19 | 0.20 | 0.21 | 0.23 |
| Clinics | 0.29 | 0.30 | 0.32 | 0.33 | 0.35 | 0.37 | 0.39 | 0.41 | 0.43 | 0.45 |
| Laboratories | 0.43 | 0.45 | 0.47 | 0.50 | 0.52 | 0.55 | 0.58 | 0.61 | 0.64 | 0.67 |
| Diagnostic Centers | 0.57 | 0.60 | 0.63 | 0.66 | 0.70 | 0.73 | 0.77 | 0.81 | 0.85 | 0.89 |
| Blood Banks | 0.71 | 0.75 | 0.79 | 0.83 | 0.87 | 0.91 | 0.96 | 1.01 | 1.06 | 1.11 |
| Pharmacies | 0.86 | 0.90 | 0.95 | 0.99 | 1.04 | 1.10 | 1.15 | 1.21 | 1.27 | 1.33 |
Virology Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.30 | 0.32 | 0.33 | 0.35 | 0.37 | 0.39 | 0.41 | 0.43 | 0.45 | 0.47 |
| LAMEA | 0.60 | 0.63 | 0.66 | 0.69 | 0.73 | 0.77 | 0.81 | 0.85 | 0.89 | 0.94 |
| Europe | 0.90 | 0.95 | 0.99 | 1.04 | 1.09 | 1.15 | 1.21 | 1.27 | 1.34 | 1.40 |
| Asia-Pacific | 1.20 | 1.26 | 1.32 | 1.39 | 1.46 | 1.53 | 1.61 | 1.69 | 1.78 | 1.87 |
Virology Market Size to Hit USD 4.92 Billion by 2035
The global virology market size surpassed USD 3 billion in 2025 and is predicted to reach around USD 4.92 billion by 2035 with a registering a CAGR of 5.07%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
